Traveka Wealth, LLC Astrazeneca PLC Transaction History
Traveka Wealth, LLC
- $205 Billion
- Q2 2024
A detailed history of Traveka Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Traveka Wealth, LLC holds 6,016 shares of AZN stock, worth $499,749. This represents 0.23% of its overall portfolio holdings.
Number of Shares
6,016
Previous 5,171
16.34%
Holding current value
$499,749
Previous $350 Million
33.93%
% of portfolio
0.23%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.39 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.54 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.37 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.05 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.46 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $257B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...